Clive Stanway
Gründer bei Stroma Biosciences Ltd.
Aktive Positionen von Clive Stanway
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
4BIO Ventures Management Ltd.
4BIO Ventures Management Ltd. Investment ManagersFinance 4BIO Ventures Management Ltd (4bio Capital Partners) is an independent venture capital firm founded in 2014 by Andrey Kozlov. The firm headquartered in London, United Kingdom. | Berater | - | - |
Atelerix Ltd.
Atelerix Ltd. Electronic Equipment/InstrumentsElectronic Technology Atelerix Ltd. engages in preserving the viability and functionality of cells at hypothermic temperatures. The company was founded on June 5, 2017 and is headquartered in Cambridge, the United Kingdom. | Direktor/Vorstandsmitglied | 21.07.2018 | - |
Stroma Biosciences Ltd.
Stroma Biosciences Ltd. Miscellaneous Commercial ServicesCommercial Services Stroma Biosciences Ltd. is a biopharmaceutical company based in Cambridge, UK. Stroma Biosciences is focused on developing novel anti-stromal therapies to treat cancer by targeting survival signals in the tumour stroma, thereby cutting this important lifeline for cancer cells. The British company's work is focused on mesenchymal stroma cells, which are essential for tumour growth and resistance to cancer therapies. Stroma Biosciences has developed a platform to develop novel first-in-class cancer therapeutics by targeting the stromal compartment. The company has a validated disease-activated platform screening primary tumour samples, and its emerging pipeline includes several stromal targets to treat both solid and haematological malignancies. The company was founded in 2020 by Ingo Ringshausen, Andrew Douglas Moore, and Clive Stanway. | Gründer | 01.01.2020 | - |
Corporate Officer/Principal | 01.01.2020 | - |
Karriereverlauf von Clive Stanway
Ehemalige bekannte Positionen von Clive Stanway
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Prolifix Ltd. | Corporate Officer/Principal | - | - |
Xenova Group Plc
Xenova Group Plc Miscellaneous Commercial ServicesCommercial Services Xenova Group Plc researches and develops pharmaceutical products. The company is focused on the development of novel drugs to treat cancer and addiction with a secondary focus in immunotherapy. It has pipeline of drug candidates in clinical development including a novel program for the treatment of high-grade glioma and TransMID. The company was founded in 1987 and is headquartered in Slough, UK | Corporate Officer/Principal | - | - |
Cancer Research Technology Ltd.
Cancer Research Technology Ltd. Medical SpecialtiesHealth Technology Cancer Research Technology Ltd. develops cancer therapeutics, vaccines, and diagnostics. The firm also provides project development, commercialization, drug discovery, clinical development, imaging, and funding services. The company was founded in 2002 and is headquartered in London, the United Kingdom. | Direktor/Vorstandsmitglied | - | - |
Technik-/Wissenschafts-/F&E-Leiter | - | - |
Ausbildung von Clive Stanway
Imperial College London | Doctorate Degree |
The University of Nottingham | Undergraduate Degree |
Statistik
International
Vereinigtes Königreich | 9 |
Operativ
Corporate Officer/Principal | 3 |
Director/Board Member | 2 |
Chief Tech/Sci/R&D Officer | 1 |
Sektoral
Commercial Services | 4 |
Consumer Services | 3 |
Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 6 |
---|---|
Cancer Research Technology Ltd.
Cancer Research Technology Ltd. Medical SpecialtiesHealth Technology Cancer Research Technology Ltd. develops cancer therapeutics, vaccines, and diagnostics. The firm also provides project development, commercialization, drug discovery, clinical development, imaging, and funding services. The company was founded in 2002 and is headquartered in London, the United Kingdom. | Health Technology |
Prolifix Ltd. | Commercial Services |
Xenova Group Plc
Xenova Group Plc Miscellaneous Commercial ServicesCommercial Services Xenova Group Plc researches and develops pharmaceutical products. The company is focused on the development of novel drugs to treat cancer and addiction with a secondary focus in immunotherapy. It has pipeline of drug candidates in clinical development including a novel program for the treatment of high-grade glioma and TransMID. The company was founded in 1987 and is headquartered in Slough, UK | Commercial Services |
4BIO Ventures Management Ltd.
4BIO Ventures Management Ltd. Investment ManagersFinance 4BIO Ventures Management Ltd (4bio Capital Partners) is an independent venture capital firm founded in 2014 by Andrey Kozlov. The firm headquartered in London, United Kingdom. | Finance |
Atelerix Ltd.
Atelerix Ltd. Electronic Equipment/InstrumentsElectronic Technology Atelerix Ltd. engages in preserving the viability and functionality of cells at hypothermic temperatures. The company was founded on June 5, 2017 and is headquartered in Cambridge, the United Kingdom. | Electronic Technology |
Stroma Biosciences Ltd.
Stroma Biosciences Ltd. Miscellaneous Commercial ServicesCommercial Services Stroma Biosciences Ltd. is a biopharmaceutical company based in Cambridge, UK. Stroma Biosciences is focused on developing novel anti-stromal therapies to treat cancer by targeting survival signals in the tumour stroma, thereby cutting this important lifeline for cancer cells. The British company's work is focused on mesenchymal stroma cells, which are essential for tumour growth and resistance to cancer therapies. Stroma Biosciences has developed a platform to develop novel first-in-class cancer therapeutics by targeting the stromal compartment. The company has a validated disease-activated platform screening primary tumour samples, and its emerging pipeline includes several stromal targets to treat both solid and haematological malignancies. The company was founded in 2020 by Ingo Ringshausen, Andrew Douglas Moore, and Clive Stanway. | Commercial Services |
- Börse
- Insiders
- Clive Stanway
- Erfahrung